Dorothy Cheung

8.1k total citations · 1 hit paper
33 papers, 934 citations indexed

About

Dorothy Cheung is a scholar working on Immunology, Epidemiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Dorothy Cheung has authored 33 papers receiving a total of 934 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Immunology, 9 papers in Epidemiology and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Dorothy Cheung's work include IL-33, ST2, and ILC Pathways (8 papers), Immune Cell Function and Interaction (8 papers) and Asthma and respiratory diseases (8 papers). Dorothy Cheung is often cited by papers focused on IL-33, ST2, and ILC Pathways (8 papers), Immune Cell Function and Interaction (8 papers) and Asthma and respiratory diseases (8 papers). Dorothy Cheung collaborates with scholars based in United States, Canada and United Kingdom. Dorothy Cheung's co-authors include Mitchell H. Grayson, Robert T. Kitchens, Michael J. Holtzman, Michelle Rohlfing, Michael Dolton, David F. Choy, Ajit Dash, Weily Soong, Tracy Staton and Alice Fong and has published in prestigious journals such as The Journal of Experimental Medicine, The Journal of Cell Biology and The Journal of Immunology.

In The Last Decade

Dorothy Cheung

27 papers receiving 904 citations

Hit Papers

Astegolimab (anti-ST2) efficacy and safety in adults with... 2021 2026 2022 2024 2021 50 100 150

Peers

Dorothy Cheung
Joanne Sonstein United States
Heather MacLeod United States
Sheryl L. Henderson United States
Jill M. Johnsen United States
Anthony A. Horner United States
Hai B. Tran Australia
Kurt Gebauer Australia
Dorothy Cheung
Citations per year, relative to Dorothy Cheung Dorothy Cheung (= 1×) peers Delphine Aldebert

Countries citing papers authored by Dorothy Cheung

Since Specialization
Citations

This map shows the geographic impact of Dorothy Cheung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dorothy Cheung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dorothy Cheung more than expected).

Fields of papers citing papers by Dorothy Cheung

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dorothy Cheung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dorothy Cheung. The network helps show where Dorothy Cheung may publish in the future.

Co-authorship network of co-authors of Dorothy Cheung

This figure shows the co-authorship network connecting the top 25 collaborators of Dorothy Cheung. A scholar is included among the top collaborators of Dorothy Cheung based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dorothy Cheung. Dorothy Cheung is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Wenhui, Dorothy Cheung, Alice Fong, et al.. (2025). Safety, Pharmacokinetics, and Immunogenicity of Astegolimab, an Anti‐ST2 Monoclonal Antibody, in Randomized, Phase I Clinical Studies. Clinical and Translational Science. 18(10). e70338–e70338.
2.
Cheung, Dorothy, et al.. (2025). Practical media formulations for rapid growth of Lactobacillus iners and other vaginal bacteria. Applied and Environmental Microbiology. 91(8). e0018325–e0018325.
3.
Mak, Lung‐Yi, Jimmy Che‐To Lai, Ken Liu, et al.. (2025). Chronic Hepatitis B Infection: Patient Guidance. Journal of Gastroenterology and Hepatology. 41(1). 61–77.
4.
Greening, Neil, Christopher E. Brightling, Ruth Tal‐Singer, et al.. (2025). S1 Randomised, placebo-controlled trial of astegolimab for COPD with frequent exacerbations: ALIENTO. A7.1–A7.
5.
Choy, David F., Evgeniya V. Nazarova, Michele A. Grimbaldeston, et al.. (2024). A Stop-gain in FUT2 Associates With Several COPD Related Phenotypes and Clinical Outcomes. A2788–A2788.
7.
Zhang, Wenhui, Dorothy Cheung, Alice Fong, et al.. (2024). Pharmacokinetics (PK) of the anti-ST2 monoclonal antibody, astegolimab. PA2987–PA2987. 2 indexed citations
8.
Hou, Xuefeng, et al.. (2023). Weak to no correlation between quantitative high-resolution computed tomography metrics and lung function change in fibrotic diseases. ERJ Open Research. 9(5). 210–2023. 2 indexed citations
9.
Maurer, Marcus, Dorothy Cheung, Xiaoying Yang, et al.. (2022). Phase 2 randomized clinical trial of astegolimab in patients with moderate to severe atopic dermatitis. Journal of Allergy and Clinical Immunology. 150(6). 1517–1524. 43 indexed citations
10.
Kelsen, Steven G., Ioana Agache, Weily Soong, et al.. (2021). Astegolimab (anti-ST2) efficacy and safety in adults with severe asthma: A randomized clinical trial. Journal of Allergy and Clinical Immunology. 148(3). 790–798. 195 indexed citations breakdown →
11.
Cheung, Dorothy, Alice Fong, Han Ting Ding, et al.. (2021). A phase 1, randomized study to evaluate safety, tolerability, and pharmacokinetics of GDC-3280, a potential novel anti-fibrotic small molecule, in healthy subjects. Pulmonary Pharmacology & Therapeutics. 69. 102051–102051. 5 indexed citations
12.
Grayson, Mitchell H., Syed-Rehan A. Hussain, Michael A. Hayward, et al.. (2018). Intestinal Microbiota Disruption Reduces Regulatory T Cells and Increases Respiratory Viral Infection Mortality Through Increased IFNγ Production. Frontiers in Immunology. 9. 1587–1587. 55 indexed citations
13.
Cheung, Dorothy, Shun-Hwa Li, Ke Yan, et al.. (2012). Expression of High-Affinity IgE Receptor on Human Peripheral Blood Dendritic Cells in Children. PLoS ONE. 7(2). e32556–e32556. 26 indexed citations
14.
Cheung, Dorothy, et al.. (2010). Mechanisms of immunotherapy: a historical perspective. Annals of Allergy Asthma & Immunology. 105(5). 340–347. 14 indexed citations
15.
Cheung, Dorothy, et al.. (2010). Cutting Edge: CD49d+ Neutrophils Induce FcεRI Expression on Lung Dendritic Cells in a Mouse Model of Postviral Asthma. The Journal of Immunology. 185(9). 4983–4987. 49 indexed citations
16.
Cheung, Dorothy, et al.. (2010). Development of atopy by severe paramyxoviral infection in a mouse model. Annals of Allergy Asthma & Immunology. 105(6). 437–443.e1. 22 indexed citations
17.
Cheung, K-John, Allen Delaney, Susana Ben‐Neriah, et al.. (2010). High resolution analysis of follicular lymphoma genomes reveals somatic recurrent sites of copy‐neutral loss of heterozygosity and copy number alterations that target single genes. Genes Chromosomes and Cancer. 49(8). 669–681. 31 indexed citations
18.
Cheung, Dorothy, et al.. (2003). Cost‐Savings Analysis of Using a Portable Coagulometer for Monitoring Homebound Elderly Patients Taking Warfarin. The American Journal of Geriatric Cardiology. 12(5). 283–287. 19 indexed citations
19.
Gong, Yunhao, Barry Matthews, Dorothy Cheung, et al.. (2002). Evidence of dual sites of action of dendrimers: SPL-2999 inhibits both virus entry and late stages of herpes simplex virus replication. Antiviral Research. 55(2). 319–329. 67 indexed citations
20.
Gong, Yunhao, Aimin Wen, Dorothy Cheung, Michelle Wong, & Stephen L. Sacks. (2001). Preclinical evaluation of docusate as protective agent from herpes simplex viruses. Antiviral Research. 52(1). 25–32. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026